Delaware’s biopharmaceutical companies research and develop new treatments and cures that improve patient health while also contributing to U.S. economic health. These companies employ highly skilled union construction workers to build state-of-the-art research and manufacturing facilities to ensure infrastructure is built to exacting standards.
Construction Employment
Union Labor & Earnings, 2015-20
Pharmaceutical & Biotech
Delaware Construction Labor Hours by Trade
Pharmaceutical & Biotech, 2015-20
7,543
Installation
1,843
Maintenance
9,387
Total hours
Largest Construction Projects
Pharmaceutical & Biotech Manufacturing, 2015-20
The Chemours Company
201 Christina Pkwy, Newark, DE 19713, USA
Newark Grassroot Chemours Discovery R&D Hub
Newark, DE
$150,000,000
2017-2020
AstraZeneca US
587 South Old Baltimore Pike, Newark, DE 19702, USA
Newark Tablets, Injectables & Oral Liquids Packaging Plant Renovation
Newark, DE
$100,000,000
2014-2017
Incyte Corporation
1815 Augustine Cut Off, Wilmington, DE 19803, USA
Wilmington Blood Cancer Therapeutics R&D Building Addition
Wilmington, DE
$70,000,000
2019-2021
Wilmington PharmaTech Company LLC
229a Lake Dr, Newark, DE 19702, USA
Newark Small Scale APIs CDMO Building Fit Out Phase I and II
Newark, DE
$18,000,000
2018-2019
The Chemours Company
Newark Grassroot Chemours Discovery R&D Hub
Newark, DE
Location
$150,000,000
Project Value
2017-2020
Years
The Chemours Company
Newark Grassroot Chemours Discovery R&D Hub
AstraZeneca US
Newark Tablets, Injectables & Oral Liquids Packaging Plant Renovation
Incyte Corporation
Wilmington Blood Cancer Therapeutics R&D Building Addition
Newark, DE
Location
$150,000,000
Project Value
2017-2020
Years
Newark, DE
Location
$100,000,000
Project Value
2014-2017
Years
Wilmington, DE
Location
$70,000,000
Project Value
2019-2021
Years
Wilmington PharmaTech Company LLC
Newark Small Scale APIs CDMO Building Fit Out Phase I and II
Newark, DE
Location
$18,000,000
Project Value
2018-2019
Years
The Chemours Company
Newark Grassroot Chemours Discovery R&D Hub
Newark, DE
Location
$150,000,000
Project Value
2017-2020
Years
AstraZeneca US
Newark Tablets, Injectables & Oral Liquids Packaging Plant Renovation
Newark, DE
Location
$100,000,000
Project Value
2014-2017
Years
Incyte Corporation
Wilmington Blood Cancer Therapeutics R&D Building Addition
Wilmington, DE
Location
$70,000,000
Project Value
2019-2021
Years
Wilmington PharmaTech Company LLC
Newark Small Scale APIs CDMO Building Fit Out Phase I and II
Newark, DE
Location
$18,000,000
Project Value
2018-2019
Years
